The FDA has recently (January 2020) approved a new indication for Ozempic : to reduce the risk of major adverse cardiovascular events in adults with T2D and known heart disease [20]
In the trial, CT-388 was administered in doses up to 24 mg, achieving a placebo-adjusted mean weight reduction of 22.5% at week 48 using the efficacy estimand
1 Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function
In both cases, the body is returning to equilibrium , not wasting away
At Neighborhood Wellness Clinic & Medical Spa, we build customized medical weight loss programs that may include prescription support, nutrition counseling, lifestyle coaching, hormone evaluation, and body composition monitoring